Biogen reported $6.28B in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
ALKERMES ALKS:US USD 290.9M 633K
Amgen AMGN:US USD 37.35B 193M
Bayer BAYN:GR EUR 39.46B 1.4B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Gilead Sciences GILD:US USD 22.95B 2.24B
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Merk MRK:US USD 28.48B 202M
Moderna Inc MRNA:US USD 922M 281M
Novartis NOVN:VX USD 21.24B 2.55B
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K